TNSMOA urges TN govt to treat Ayush physicians under NRHM on par with other govt doctors

Posted on Updated on

The state conference of the Tamil Nadu Siddha Medical Officers Association (TNSMOA) has demanded to the TN government that the Ayush medical graduates hired for the scheme of NRHM should be absorbed into the regular payroll of the state services and given salaries on a par with other government doctors in the Ayush sector.

According to sources in the association, 475 Ayush doctors are working in Tamil Nadu under the scheme as Ayush Medical Consultants and all of them are on contract basis. The association said such medical consultants should be allowed to take a special qualifying examination and those who clear the test be appointed on regular services and extended all facilities given to the regular doctors.

The prime agenda of the state conference was to express gratitude to the state chief minister for allotting Rs.169 crore in the previous year’s budget (2013-14) for the development of ISM sector in the state. Dr Thamizhan Kani, joint secretary of the association said the thanks giving meeting was done this time because the fund was forwarded to the directorate in last month only.

He said the government doctors have given one memorandum to the government requesting creation of Siddha wing in all the additional primary health centres. The memorandum also wanted to fill up the vacant posts in the two government Siddha medical colleges immediately. Posts of Joint Directors, RMOs and Superintendents are lying vacant in the colleges, Dr Kani added.

According to TNSMOA, the designation of District Siddha Medical Officer should be changed to Joint Director-Siddha like as in allopathic system.

Last year the state government sanctioned Rs.169 crore for the development of ISM sector, out of which Rs.52 crore was set aside for siddha system. For Research & Development in Indian Medicine, the amount allotted was Rs.10 crore. Rs.15 crore was allotted for the improvement of infrastructure at the Ayush colleges.

Source: PharmaBiz


Let us know what you think!

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s